BBHC
FLXN

Brown Brothers Harriman & Co’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Brown Brothers Harriman & Co’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,400
Closed -$19K – 1332
2019
Q3 		$19K Hold
1,400
– – ﹤0.01% 808
2019
Q2 		$17K Hold
1,400
– – ﹤0.01% 769
2019
Q1 		$17K Buy
+1,400
New +$18.7K ﹤0.01% 759

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Brown Brothers Harriman & Co's FLXN Position: Q4 2019 in Review

Brown Brothers Harriman & Co sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2019, closing a stake of 1,400 shares — an estimated $19K sold.

Brown Brothers Harriman & Co first reported a position in FLXN in Q1 2019 and held it in 3 quarters. The position peaked at $19K in Q3 2019. 133 funds tracked by Wall St. Rank hold FLXN as of Q4 2019.

  • Brown Brothers Harriman & Co reported no remaining Flexion Therapeutics, Inc. position as of Q4 2019 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 1,400 Flexion Therapeutics, Inc. shares in Q4 2019, an estimated $19K.
  • Brown Brothers Harriman & Co first reported a position in Flexion Therapeutics, Inc. in Q1 2019 and held it in 3 quarters.
  • Brown Brothers Harriman & Co's Flexion Therapeutics, Inc. position peaked at $19K in Q3 2019.
  • 133 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2019.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2019, filed 14 Feb 2020.